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PURPOSE. To investigate the prevalence and determinants of diabetic retinopathy (DR) among
older adults in rural Southern China.
METHODS. Using random cluster sampling, persons aged 50 years or older were randomly
selected in rural Yangxi County, Guangdong Province, China. All participants underwent a
standardized interview, fundus photography, and point of service glycosylated hemoglobin
A1c (HbA1c) testing. Diabetes mellitus (DM) was diagnosed based on confirmed medical
history or HbA1c ‡6.5%. Fundus photographs were graded for DR and diabetic macular
edema (DME) based on the United Kingdom National Diabetic Eye Screening Program
guidelines. Prevalence of and risk factors for DR and vision-threatening diabetic retinopathy
(VTDR) were evaluated.
RESULTS. Among 5825 subjects who participated (90.7% response rate) in the Yangxi Eye
Study, 562 (9.6%) were diagnosed with DM, including 79 (14.1%) known and 483 new
(85.9%) cases. Among DM cases, 476 (84.7%) had gradable fundus photos. The prevalence of
any DR and VTDR were 8.19% (95% confidence interval [CI] 5.9–11.0) and 5.25% (95% CI
3.43–7.66), respectively. These figures were 23.9% and 12.7% for known and 5.43% and 3.95%
for new DM cases. Risk factors for any DR were higher HbA1c level (OR [odds ratio] per unit
1.34, P < 0.001), longer duration of DM (OR per year ¼ 2.29, P < 0.001) and having
previously undergone cataract surgery (OR 4.11, P < 0.030).
CONCLUSIONS. Our study found a lower prevalence of DR among adults 50 years and older than
in previously reports. Perhaps this difference can be explained by the short duration of most
cases.
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The total number of people with diabetes mellitus (DM) inChina is projected to rise from 171 million in 2000 to 366
million by 2030, meaning that China will become the country
with the largest diabetes population in the world.1 Diabetic
retinopathy (DR), a common complication of diabetes, is the
leading cause of blindness in the working age population
worldwide.2–4 The global prevalence of DR grew 64% from
1990 to 2010, virtually all due to increases in low- and middle-
income countries, but few population-based data from such
settings have been published.5–8 Reports from upper-income
countries are comparatively plentiful,8–20 and substantial
regional variation has been identified.21
China is the world’s most populous country, with one-half of
its 1.4 billion people living in rural areas.22 However,
population-based data on the prevalence of DM and DR in
China remained limited,23–27 particularly in rural areas, where
only a single study has been conducted, in Handan, northern
China, more than 10 years ago. With the diabetes population
increasing rapidly in China,28,29 an up-to-date study on the rural
prevalence of DR is needed by policy makers to assess the
current magnitude of the disease and requirements for service
delivery. Additional population-based data would also help
quantify regional variation in a large country such as China,
where genetic background, lifestyle, and quality of and access
to healthcare services differ considerably from region to region.
In the current study, we investigated the age- and sex-
specific prevalence of DM and DR and potential predictors in a
large, population-based cohort in rural southern China.
MATERIALS AND METHODS
Study Population
The Yangxi Eye Study is a population-based, cross-sectional
study of Han Chinese age 50 years or older living in a rural
setting in southern China. As part of the 2014 China Nine-
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Province Survey, this study of visual impairment and blindness
was designed to report the prevalence and clinical character-
istics of eye diseases, including DR and age-related macular
degeneration.30 From August to November 2014, based on data
from the Residence Administrative Committee, 6425 eligible
subjects were identified using cluster random sampling from
268 geographically defined basic sampling units. The subjects
underwent full ocular examinations. The research followed the
tenets of the Declaration of Helsinki, written informed consent
was obtained from all the participants, and the study was
approved by the Institutional Review Board of Zhongshan
Ophthalmic Center (Guangzhou, China).
Study Procedures
Eligible participants, persons age 50 years and older who had
been living in the catchment area for at least 6 months, were
recruited based on a household registry and door-to-door
enumeration. A standard questionnaire conducted by trained
interviewers was used to collect past medical history regarding
DM, including the date of confirmed diagnosis and current use
of medications. Glycosylated hemoglobin A1c (HbA1c) was
analyzed using a point-of-care device (Afinion AS100; Axis-
Shield, Norway). New diabetes mellitus (NDM) was diagnosed
by HbA1c ‡6.5%, as recommended by the America Diabetes
Association,31 and known diabetes mellitus (KDM) was defined
as a self-reported history of physician diagnosis or current drug
treatment for diabetes. A systemic examination was performed
by a trained nurse, including the measurement of blood
pressure and height and weight for the computation of body
mass index (BMI).
Basic eye examinations were performed after the interview
and the aforementioned systemic examination, according to
standardized protocol. Visual acuity was assessed with Early
Treatment Diabetic Retinopathy Study (ETDRS) charts.32 The
presenting visual acuity (PVA) of each eye with habitual
correction where available was recorded, and the best
corrected visual acuity (BCVA) was assessed with noncyclo-
plegic automated refraction (KR-8900; Topcon, Tokyo, Japan)
in those with PVA <6/12 in either eye. Slit-lamp biomicroscopy
and direct ophthalmoscopy were performed by trained
ophthalmologists to identify and record abnormalities of the
anterior and posterior segments.
Fundus photography was undertaken for each eye in all
participants using a digital non-mydriatic fundus camera
(FundusVue; Crystalvue, Inc., Ltd., Taoyuan City, Taiwan),
consisting of NHS screening program standard field 1 (centered
on the optic disc) and field 2 (centered on the fovea).33 Pupils
were dilated by applying compound tropicamide eye drops
(each milliliter contains 5 mg tropicamide and 5 mg
phenylephrine hydrochloride), 3 drops in each eye.
Diabetic Retinopathy Grading
Retinal photographs were graded by trained graders according
to the United Kingdom National Diabetic Eye Screening
Program (UK NDESP) guidelines.33 DR was graded as R0, R1,
R2, R3a, or R3s. R0 was defined as no DR and R1 as
background DR with at least one of the following features:
microaneurysm(s) or HMa (a term used when it is difficult to
distinguish between a microaneurysm and a dot hemorrhage);
retinal hemorrhage(s); venous loop(s); any exudate in the
presence of other non-referable features of DR; or any number
of cotton wool spots in the presence of other non-referable
features of DR. R2 was defined as pre-proliferative DR with at
least one of the following features: venous beading, venous
reduplication, multiple blot hemorrhages, or intraretinal
microvascular abnormality. R3 was classified into two groups:
R3a was defined as active proliferative retinopathy with at least
one of these features: new vessels on the disc, new vessels
elsewhere, pre-retinal or vitreous hemorrhage, or pre-retinal
fibrosis with or without retinal traction. R3s was defined as
stable post-treatment retinopathy, with evidence of previous
peripheral retinal laser treatment. R3s was rare in this study’s
setting and was therefore combined with R3a to report the
prevalence of R3.
Diabetic macular edema (DME) was graded as M0 or M1. M0
was defined as no maculopathy, and M1 had at least one of the
following features: exudate within 1 disc diameter of the
center of the fovea, or a collection of exudates within the
macula. Vision-threatening DR (VTDR) was considered to be
present if any feature(s) of M1, R2, or R3 were found.
Photographs were classified as ungradable if quality precluded
classification according to the above system.
DR was graded based on the worse-affected eye for each
participant, as previously described.34 In particular, if one eye
was ungradable and the other was gradable, the participant
would be classified based on the gradable eye.
As called for in the NDESP protocol,33 two trained,
experienced graders graded each image independently, based
on the protocol as outlined. If there was any discrepancy
between them, the image was reassessed by a senior grader
(ophthalmologist), whose decision was final. These graders
were trained and certified in the UK NDESP national screening
program online course35 and had worked as service providers
for a national diabetes screening program run by the Chinese
Ministry of Health. The interobserver agreement between the
graders was good (weighted j 0.84 for retinopathy and 0.73 for
DME).
Statistical Analyses
Overall, age-specific and sex-specific prevalence of DR and its
component signs were assessed. Chi-square and Mann-Whitney
U tests were used to compare characteristics between sexes
and different age groups. Multivariate-adjusted logistic regres-
sion analysis of risk factors for the development of DR was also
performed. The impact of diabetes on vision impairment was
assessed, and prevalence of visually significant comorbid eye
disease were compared between groups with and without
diabetes. According to WHO criteria, visual impairment was
categorized as: <6/18–6/60 (moderate visual impairment), <6/
60–6/120 (severe visual impairment), and >6/120 (blind-
ness).36 All data analyses were performed using Stata 14.0
software (Stata Corp., College Station, TX, USA). P value <0.05
was considered statistically significant.
RESULTS
Of 6425 eligible participants, 5825 (90.7%) took part in the
study. Hb1Ac results were available for 5742 (98.6%) partici-
pants, and medical history data available for 5744 (98.6%). A
total of 562 persons (9.6%) were diagnosed with DM, including
79 (14.1%) known DM (KDM) and 483 (85.9%) new DM
(NDM) cases. Among the DM cases, 476 (84.7%; mean age 65.7
6 9.48 years, 37.2% men) had gradable photos in at least 1 eye,
including 34 persons were graded as non-VTDR in one eye and
ungradable in the fellow eye (Fig. 1). Characteristics of all
persons with DM are shown in Supplementary Table S1.
Participants without gradable photos were significantly older
(P¼ 0.012) and significantly more likely to have PVA <6/18 (P
< 0.001). Characteristics of NDM and KDM participants with
gradable fundus photographs are shown in Table 1.
Table 2 shows the age- and sex-specific prevalence of DR
among participants with DM. The overall prevalence of DR in
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this cohort was 8.19% (95% CI, 5.9%–11.0%). VTDR was
present in 5.25% (95% CI, 3.43%–7.66%), and M1 in 3.58%
(95% CI, 2.10%–5.67%) of participants with DM. The preva-
lence of DR, M1 and VTDR did not differ significantly by age or
sex (Table 2).
Table 3 shows the prevalence of DR in those with KDM and
NDM. Compared with NDM subjects, KDM subjects had
significantly higher prevalence of any DR (23.9% vs. 5.43%, P
< 0.001) and VTDR (12.7% vs. 3.95%, P ¼ 0.002) but not M1
(5.63% vs. 3.22%, P¼0.312). Both the presence and severity of
DR increased significantly with longer duration of diabetes
(Fig. 2). Any DR was present in 40% of KDM participants with a
10-year history of diabetes, compared to 5.43% of NDM
participants (P < 0.001).
Table 4 shows the associations of various potential
determinants of any DR and of VTDR. In multivariate analysis,
factors significantly associated with any DR were higher HbA1c
(OR, 1.34 per 1% increase, P < 0.001) and longer diabetes
duration (OR, 2.29 per year increase, P < 0.001). HbA1c (OR,
1.32 per 1% increase, P < 0.002) and longer diabetes duration
(OR, 1.82 per year increase, P < 0.019) were also risk factors
for VTDR.
A total of 546 (97.2%) participants with DM completed
assessment of PVA, as did 5021 without DM (95.4%). The
prevalence of moderate and severe visual impairment and
blindness among those with diabetes was 3.66% (95 CI, 2.25%–
5.60%), 1.28% (95 CI, 0.52%–2.62%), and 2.38% (95 CI, 1.27%–
4.04%), respectively, and did not differ significantly from rates
among those without diabetes (Table 5). Visual impairment
associated with glaucoma was significantly higher among
participants with DM than without DM, but the rates for
cataract and refractive error did not differ significantly by DM
status.
DISCUSSION
In the current study, we chose to use the UK NDESP
classification to assess the severity of DR because our graders
had been trained and certified using this system. Although the
UK NDESP classification system differs from research grading
systems such as that used in the ETDRS,37 it is capable of
classifying referral DR and VTDR cases, has been widely used
in DR screening programs, and is less resource-intensive and
time-consuming for patients.34,38,39 In these respects, it was
more suitable in this low-resource setting.
A number of studies have been carried out on DR
prevalence worldwide to date. A retrospective study pooling
of 35 population-based studies from the United States,
Australia, Europe, Asia, and other countries and regions over
the past 30 years (1980–2008) reported that the mean
prevalence of DR and VTDR were 34.6% and 7.0%, respective-
ly, among persons with DM.21 The prevalence of DR and VTDR
identified in our study was much lower than reported in
developed countries in Europe,12,40–43 the United
States,9,10,13,14,44 Australia,11,45,46 and Asia (Singapore).15 Inter-
estingly, reported prevalence of any DR from another low- to
middle–income country (India: 10.3%–18.0%)8,16 was more in
line with our own findings in rural China. However, our
observed prevalence of any DR was also lower than has been
FIGURE 1. Flowchart of participants included and excluded from
analysis for diabetes and diabetic retinopathy in the Yangxi Eye Study.
TABLE 1. Characteristics of New Diabetes Mellitus and Known Diabetes Mellitus in the Yangxi Eye Study
Total NDM KDM
P Value(n ¼ 476) (n ¼ 405) (n ¼ 71)
Mean (Standard Deviation)
Age (years) 65.7 6 9.48 65.7 6 9.61 65.5 6 8.75 0.838
Body mass index (kg/m2) 23.9 6 4.03 23.9 6 4.15 24.1 6 3.28 0.802
Systolic blood pressure (mm Hg) 147.4 6 24.7 146.5 6 25.1 152.3 6 22.4 0.071
Diastolic blood pressure (mm Hg) 76.5 6 13.5 76.5 6 13.8 77.0 6 11.7 0.744
HbA1c (%) 7.62 6 1.77 7.46 6 1.52 8.48 6 2.65 <0.001
Spherical equivalent (right eye) 0.22 6 1.77 0.13 6 1.81 0.66 6 1.46 0.027
Number (%)
Male 177 (37.2) 155 (38.3) 22 (31.0) 0.241
Hypertension 296 (62.2) 243 (60.0) 53 (74.7) 0.019
Self-reported hypertension 65 (13.7) 42 (10.4) 23 (32.4) <0.001
Education (high school or higher) 8 (1.68) 8 (1.98) 0 (0.00) 0.232
Previous cataract surgery (at least 1 eye) 22 (4.63) 21 (5.20) 1 (1.41) 0.161
PVA <6/18a 72 (15.5) 61 (15.5) 11 (15.5) 0.998
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TABLE 2. Age- and Sex-Specific Prevalence of Diabetic Retinopathy in the Yangxi Eye Study
DR Grade
Total
(n ¼ 476)
Age Group (years) % (95% CI)
P
Value
Sex % (95% CI)
P
Value50–59 (n ¼ 136) 60–69 (n ¼ 179) 70þ (n ¼ 161) Men (n ¼ 177) Women (n ¼ 299)
Any DR 8.19 (5.9–11.0) 8.09 (4.11–14.0) 9.50 (5.63–14.8) 6.83 (3.46–11.9) 0.669 6.21 (3.14–10.8) 9.36 (6.8–13.2) 0.226
R0 91.8 (89.0–94.1) 91.9 (86.0–95.9) 90.5 (85.2–94.4) 93.2 (88.1–96.5) 0.669 93.8 (89.2–96.9) 90.6 (86.8–93.7) 0.226
R1 5.88 (3.94–8.39) 5.89 (2.57–11.3) 7.26 (3.92–12.1) 4.35 (1.77–8.75) 0.522 5.08 (2.35–9.43) 6.35 (3.87–9.75) 0.569
R2 1.89 (0.87–3.56) 1.03 (0.18–5.21) 1.68 (0.35–4.82) 2.48 (0.68–6.24) 0.787 0.56 (0.01–3.11) 2.68 (1.16–5.20) 0.102
R3 0.42 (0.05–1.51) 0.73 (0.02–4.03) 0.56 (0.01–3.07) 0 (0–2.27) 0.582 0.56 (0.01–3.11) 0.33 (0.01–1.85) 0.720
M1 3.58 (2.10–5.67) 2.94 (0.81–7.36) 4.47 (1.95–8.62) 3.12 (1.02–7.14) 0.716 1.69 (0.35–4.87) 4.70 (2.59–7.76) 0.088
VTDR 5.25 (3.43–7.66) 4.41 (1.64–9.36) 6.15 (3.11–10.7) 4.97 (2.17–9.56) 0.777 2.82 (0.92–6.46) 6.69 (4.13–10.1) 0.068
TABLE 3. Prevalence of Diabetic Retinopathy in Those With Known Diabetes Mellitus and Newly Diagnosed Diabetes Mellitus in the Yangxi Eye Study
DR Grading
Total (n ¼ 476) KDM (n ¼ 71) NDM (n ¼ 405)
OR (95% CI)*
P
Valuen (%) n (%) n (%)
Any DR 39 (8.19) 17 (23.9) 22 (5.43) 5.48 (2.74–11.0) <0.001
R1 28 (5.88) 10 (14.1) 18 (4.44) 3.94 (1.73–8.98) 0.001
R2 9 (1.89) 6 (8.45) 3 (0.74) 12.5 (3.06–51.4) <0.001
R3 2 (0.42) 1 (1.41) 1 (0.25) 5.78 (0.36–93.3) 0.163
M1 17 (3.58) 4 (5.63) 13 (3.22) 1.80 (0.57–5.67) 0.312
VTDR 25 (5.25) 9 (12.7) 16 (3.95) 3.53 (1.49–8.34) 0.002
* Logistic regression analysis with KDM as the dependent variable for the type of DR and ME.
TABLE 4. Risk Factors for Presence of Any Diabetic Retinopathy in the Yangxi Eye Study
Factors
Any DR VTDR
Age–Sex Adjusted Multivariate Adjusted Age–Sex Adjusted Multivariate Adjusted
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Male 0.64 (0.31–1.33) 0.233 0.85 (0.38–1.91) 0.700 0.40 (0.15–1.10) 0.076 0.46 (0.16–1.31) 0.143
Age (per 10 years) 0.92 (0.61–1.39) 0.688 0.73 (0.44–1.21) 0.225 1.06 (0.64–1.76) 0.822 0.93 (0.52–1.64) 0.794
Systolic BP (per mm Hg) 1.16 (1.02–1.32) 0.028 1.11 (0.96–1.30) 0.159 1.13 (0.96–1.33) 0.128 – –
Diastolic BP (per mm Hg) 0.85 (0.65–1.10) 0.214 – – 0.75 (0.54–1.04) 0.085 – –
BMI† (per kg/m2) 0.93 (0.84–1.03) 0.168 0.98 (0.87–1.10) 0.747 0.90 (0.79–1.02) 0.102 0.97 (0.85–1.12) 0.692
HbA1c, (per 1%) 1.44 (1.26–1.65) <0.001 1.34 (1.16–1.56) <0.001 1.40 (1.20–1.64) <0.001 1.32 (1.11–1.56) 0.002
Duration of DM (per year) 2.43 (1.68–3.54) <0.001 2.29 (1.51–3.47) <0.001 1.93 (1.23–3.03) 0.004 1.82 (1.11–2.99) 0.019
Hypertension 1.67 (0.79–3.52) 0.182 – – 1.86 (0.71–4.90) 0.209 – –
Duration of hypertension
(per year)
0.58 (0.34–1.01) 0.054 – – 0.19 (0.03–1.47) 0.112 – –
Use of insulin or hypoglycemic
drugs
1.00 (0.18–5.58) 0.998 – – – – – –
Education
(middle school or higher)
0.51 (0.12–2.21) 0.364 – – 0.46 (0.06–3.54) 0.454 – –
Cataract surgery
(at least 1 eye)
3.22 (0.99–110.5) 0.052 4.11 (1.15–14.7) 0.030 3.73 (0.97–14.4) 0.056 4.42 (1.07–18.2) 0.040
Spherical equivalent
(per diopter)
1.12 (0.89–1.42) 0.312 – – 1.01 (0.78-1.31) 0.943 – –
TABLE 5. Impact of Diabetes on Visual Impairment and Visually Significant Comorbid Eye Disease in the Yangxi Eye Study
Visual Impairment All
With
Diabetes
Without
Diabetes
Unadjusted
Comparison
P Value
Adjusted
Comparison*
P Value
Moderate visual impairment† n (%) 228 (4.10) 20 (3.66) 208 (4.14) 0.651 0.599
Severe visual impairment‡ n (%) 56 (1.01) 7 (1.28) 49 (0.98) 0.495 0.633
Blindness§ n (%) 96 (1.72) 13 (2.38) 83 (1.65) 0.223 0.288
Cataract associated with VA <6/18 in either eye 278 (5.00) 33 (6.04) 245 (4.84) 0.254 0.779
Glaucoma associated with VA <6/18 in either eye 8 (0.14) 3 (0.55) 5 (0.10) 0.008 0.025
Refractive error associated with VA <6/18 in either eye 26 (0.47) 1 (0.18) 25 (0.50) 0.306 0.341
* Adjusting for age and sex.
† Presenting visual acuity <6/18 and ‡6/60 in the better-seeing eye.
‡ Presenting visual acuity <6/60 but ‡3/60 in the better-seeing eye.
§ Presenting visual acuity <3/60 in the better-seeing eye.
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reported in other population-based studies conducted in China
(Supplementary Table S2), with values ranging from 9.9% to
43.1%.23–27
There are several possible explanations for the low
prevalence of DR observed in the current study: First, different
characteristics of the study populations might contribute to the
discrepancy. The ratio between KDM to NDM was 1:5 in the
current study, which is substantially lower than that identified
in developed countries or the findings from the Handan Eye
Study conducted in northern rural China (ratio¼ 1:2),11,12,47,48
presumably due to relatively poor access to care in our study
setting. Given the fact that DR was much less common in NDM
patients,27 presumably due to their shorter mean duration and
possibly lesser severity of disease, this is a likely explanation for
the low prevalence of DR observed in our study. Second, race,
which is considered an independent risk factor for DR, is
another possible reason.21,49 Many studies have investigated
the relationship between ethnicity and DR, with typical
associations to be dependent on differences in the control of
established risk factors.14,50 However, some studies have
identified ethnicity as an independent risk factor for DR that
could not otherwise be explained.44,51 Third, regional differ-
ences between northern and southern China, secondary to
lifestyle, environmental differences and variations in access to
care, may be another factor contributing to the discrepancy.
Regional differences within the same ethnic group—for
example, between Indian migrants to Singapore and those
remaining in India—have also been reported in the Singapore
Indian Eye Study.18
We identified both HbA1c and longer duration of DM as risk
factors for both DR and VTDR, but no such association was
present for age, BMI, hypertension, and insulin use. Our
findings for Hb1Ac and DM duration are consistent with
previous studies.15,17,27,52 HbA1c reflects glycemic levels over
the past 3 months, and DM duration is an index of cumulative
damage to the microvascular system. Therefore, it is biologi-
cally plausible that these factors may be linked causally with
the presence and severity of DR.
Strengths of this study include the population-based design
with large sample size, high participation rate, and the use of
recommended HbA1c testing (shown to be more accurate in
assessment of DM than is random plasma glucose31). Limita-
tions of the study must also be addressed: First, although the
UK NDESP grading system was suitable for this rural Chinese
setting, differences in photographic protocol and cutoffs limit
our comparison with studies based on other systems. Second,
data on other biomarkers that are potentially important in the
DR pathway (including genetic factors and blood lipids) were
not collected here; therefore, an assessment of their effects on
DR is not possible. Third, consistent with previous studies,15,27
we used nonstereoscopic digital photography, which may
affect the accuracy for DME classification, where stereoscopic
findings can be important.
In conclusion, prevalence of DR and VTDR among persons
with diabetes in this population was far lower than has been
reported previously in rural China.27 The four-fold difference
(between 10% and 40%) has important implications for human
resource and equipment needs across the very large popula-
tions of rural China. Furthermore, the high proportion of
previously undiagnosed diabetes observed in our study
suggests that further efforts are needed to improve access to
basic healthcare in at least some parts of rural China. Additional
studies are required to confirm these findings elsewhere and
elucidate reasons for possible regional variations in DM and DR
prevalence across China.
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